Sponsor Pipeline

Maze Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
1
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-28 NCT06830629
A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease		 Enrollment increased: 56 -> 74 participants
Active Trials by Phase
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07694440 A Study of MZE782 in Adults With PKU Phenylketonuria (PKU) Recruiting
NCT06830629 A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease Proteinuric Kidney Disease Recruiting
Disease Areas
Chronic Kidney Disease (1)
Get alerts when Maze Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free